Effects of Postbiotics on Mood Disorders in Korean Adults
Launched by HANYANG UNIVERSITY · May 18, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is looking at how postbiotics, which are beneficial compounds produced by the fermentation of probiotics, might help improve mood disorders in Korean adults. The researchers want to see if these postbiotics can make a difference for people who are experiencing symptoms of depression. The study has not started recruiting participants yet, but they are planning to include adults between the ages of 19 and 39 who have a certain level of depression, as measured by a standard questionnaire.
To be eligible for this study, participants need to have a body mass index (BMI) that falls within a specific range and be able to complete an online survey. However, some individuals won’t qualify, such as those who have participated in other clinical trials recently, have taken certain medications related to mental health or gut health, or have specific health conditions. Participants can expect to contribute to research that could help improve treatments for mood disorders, but they should also be aware that there are strict criteria for joining the study.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Adults aged between 19 and 39 years at the time of screening.
- • BMI between 18.5 and 30 at the time of screening.
- • CES-D (Center for Epidemiologic Studies Depression Scale) score of 16 or higher.
- • Ability to access and respond to the survey via an online link.
- Exclusion Criteria:
- • Participation in any human clinical trial within the past 3 months before screening.
- • History of antipsychotic medication treatment within the past 3 months before screening.
- • Presence of chronic diseases, including cardiovascular, endocrine, immune, respiratory, hepatobiliary, renal and urological, neurological, musculoskeletal, inflammatory, hematological, oncological, or gastrointestinal disorders.
- • Use of medications or health supplements related to gut health and mood disorders (e.g., antibiotics, laxatives, antidiarrheals, prebiotics, probiotics, postbiotics, anxiolytics, antidepressants, etc.) within 1 month prior to participation in the study.
- • History of significant hypersensitivity to postbiotics or starch.
- • Alcohol addiction, drug abuse, or suspicion of substance misuse.
- • Pregnant or breastfeeding women.
- • Any other reasons that the study investigator deems the participant unsuitable for participation.
About Hanyang University
Hanyang University is a prestigious educational and research institution located in South Korea, renowned for its commitment to advancing scientific knowledge and innovation. With a strong emphasis on interdisciplinary collaboration, the university conducts cutting-edge research across various fields, including medicine, engineering, and biotechnology. As a clinical trial sponsor, Hanyang University leverages its robust academic resources and expertise to facilitate the design, implementation, and management of clinical studies. The institution is dedicated to improving patient outcomes through rigorous research methodologies and ethical standards, contributing to the advancement of healthcare and the development of novel therapeutic interventions.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Seoul, , Korea, Republic Of
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported